Cover Image
市場調查報告書

全球胰島素幫浦市場,用戶數,預測,償付政策,臨床試驗,練習用模式,企業分析

Global Insulin Pump Market, Users, Forecast, Reimbursement Policy (US, Canada, Germany, Australia, France, Netherlands, Switzerland, Sweden, Israel, UK & Japan) Clinical Trials, Training Model, Companies Analysis - 2nd Edition

出版商 Renub Research 商品編碼 293357
出版日期 內容資訊 英文 240 Pages; 123 Figures; 12 Tables
商品交期: 最快1-2個工作天內
價格
Back to Top
全球胰島素幫浦市場,用戶數,預測,償付政策,臨床試驗,練習用模式,企業分析 Global Insulin Pump Market, Users, Forecast, Reimbursement Policy (US, Canada, Germany, Australia, France, Netherlands, Switzerland, Sweden, Israel, UK & Japan) Clinical Trials, Training Model, Companies Analysis - 2nd Edition
出版日期: 2017年10月03日 內容資訊: 英文 240 Pages; 123 Figures; 12 Tables
簡介

全球胰島素幫浦市場,預計至2024年超越80億美元。

本報告提供全球胰島素幫浦市場相關調查分析,市場與預測,償付政策,練習用模式,差異化點,臨床試驗,企業分析,成長推動因素,課題相關的系統性資訊。

第1章 摘要整理

第2章 全球胰島素幫浦用戶數與預測

第3章 全球胰島素幫浦市場與預測

第4章 全球胰島素幫浦市場佔有率與預測

  • 11個國家
  • 各企業

第5章 患者與HCP (醫護人員)的練習用模式

  • Medtronic
  • Insulet Corporation
  • Animas Corporation
  • Tandem Diabetes Care

第6章 全球可利用的胰島素幫浦產品的差異化點

  • Animas Vibe
  • Medtronic 530G with Enlite
  • Insulet OmniPod
  • Tandem t:slim
  • Roche Accu-Chek Combo

第7章 美國的糖尿病人口

  • 糖尿病人口
  • 第一型糖尿病人口
  • 第二型糖尿病人口

第8章 美國的胰島素分析

  • 胰島素幫浦用戶數與預測
  • 胰島素幫浦市場與預測
  • 各州:胰島素幫浦的償付政策

第9章 加拿大的糖尿病分析

  • 糖尿病人口與預測
  • 第一型糖尿病人口與預測
  • 第二型糖尿病人口

第10章 加拿大的胰島素幫浦分析

  • 胰島素幫浦用戶數與預測
  • 胰島素幫浦市場與預測
  • 各州:胰島素幫浦的償付政策

第11章 德國的糖尿病分析

第12章 德國的胰島素幫浦分析

第13章 澳洲的糖尿病分析

第14章 澳洲的胰島素幫浦分析

第15章 法國的糖尿病分析

第16章 法國的胰島素幫浦分析

第17章 荷蘭的糖尿病分析

第18章 荷蘭的胰島素幫浦分析

第19章 瑞士的糖尿病分析

第20章 瑞士的胰島素幫浦分析

第21章 瑞典的糖尿病分析

第22章 瑞典的胰島素幫浦分析

第23章 以色列的糖尿病分析

第24章 以色列的胰島素幫浦分析

第25章 英國的糖尿病分析

第26章 英國的胰島素幫浦分析

第27章 日本的糖尿病分析

第28章 日本的胰島素幫浦分析

第29章 主要企業分析

  • Medtronic
  • Insulet Corporation
  • Tandem Diabetes Care

第30章 企業的胰島素幫浦臨床試驗

  • Medtronic
  • Insulet Corporation
  • Tandem Diabetes Care
  • Roche
  • Animas Corporation

第31章 成長推動因素

第32章 課題

第33章 附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

Global insulin pump market is expected to cross US$ 8 Billion by 2024. The expansion of diabetes management policy and addition of diabetes technology across the world, the market for insulin pump will cultivate positive outlook in an anticipated year. With the help of insulin pump patients manage their diabetes with high degree of efficiency without frequent support from physician. In addition, there are lots of assessments has been done so far associated with insulin pump and it shows quite favorable results.

United States captures more than half of the Insulin Pump Global Market

The better implementation of public & private reimbursement policy regarding insulin pump makes United States world's largest insulin pump market. Moreover people in United States are well informed about insulin pump and they know it can be used to manage severe diabetes complication either occurred by type 1 diabetes or type 2 diabetes.

Germany has the Largest Number of Insulin Pump User in Europe

Germany records the highest number of insulin pump user due its overall population and relatively more number of type 1 diabetes patients in Europe.

Reimbursement Policy Analysis

Reimbursement policy of USA and Australia is considered to be one of the best compared to all the other 11 countries studied in the report.

Global Insulin Pump Market, Users, Forecast, Reimbursement Policy (Countries: US, Canada, Germany, Australia, France, Netherlands, Switzerland, Sweden, Israel, UK & Japan) Clinical Trials, Training Model, Companies Analysis is the 2nd edition published by Renub Research on Insulin Pump Market. This 240 page report with 123 Figures and 12 Tables provides a detailed and comprehensive insight of the Global Insulin Pump Market.

image1

Scope of the Report

  • Insulin Pump Market & Forecast: We have defined insulin pump market and volume of user of 11 countries. Market data from 2010 to 2016 and Forecast from 2017 to 2024.
  • Reimbursement Policy: Report provides details of separate reimbursement policy for 11 countries including Insulin Pumps, Diabetes Supplies (Blood Glucose Devices, Test Strips, Lancets, Disposable Needles, Syringe, Ketone Urine Testing Strips, Pen Delivery etc)
  • Training Models: This topic shows through flow chart method, how a company provides training. This segment companies Training program for its staff includes physicians, Certified Diabetes Educators (including nurse educators, dietitians and exercise physiologists) and support staff with expertise in insulin pump therapy and Training program for patients have been described through flow chart method. In total 4 companies Medtronic, Insulet Corporation, Animas Corporation & Tandem Diabetes Care Training program has been studied in the report.
  • Differentiation Points of Insulin Pump Products: This topic discusses the Advantages and Drawbacks of the following insulin pumps: Animas Vibe, Medtronic 530G with Enlite, Insulet OmniPod, Tandem t:slim, Roche Accu-Chek Combo.
  • Clinical Trials of Insulin Pumps: Report captures details of clinical trials results for companies on Insulin Pumps. The report captures details of the following companies Medtronic, Insulet Corporation, Tandem Diabetes Care, Roche and Animas Corporation.
  • Companies Analysis: All the 3 companies have been covered from the following points: Overview, Product Details, Insulin Pump Sales Analysis and Latest Development & Trends in their insulin pumps. The three companies studied in the report are as follows: Medtronic, Insulet Corporation and Tandem Diabetes Care.
  • Growth Drivers for Insulin Pumps: This topic studies the factors which is helping the Insulin Pump industry to grow.
  • Challenges for Insulin Pumps: This industry shows the problems being faced by the insulin Pump industry.

Key Companies Covered

  • 1. Medtronic
  • 2. Insulet Corporation
  • 3. Tandem Diabetes Care

Countries Covered

  • 1. United States
  • 2. Canada
  • 3. Germany
  • 4. Australia
  • 5. France
  • 6. Netherlands
  • 7. Switzerland
  • 8. Sweden
  • 9. Israel
  • 10. United Kingdom
  • 11. Japan

Table of Contents

1. Executive Summary

2. Global - Insulin Pump Users & Forecast

3. Global - Insulin Pump Market & Forecast

4. Global - Insulin Pump Market Share & Forecast

  • 4.1 By 11 Countries - United States, United Kingdom, Israel, Germany, Netherlands, Sweden, France, Switzerland, Australia, Japan, Canada
  • 4.2 By Companies - Medtronic Inc, Insulet Corporation, Tandem Diabetes Care, Others

5. Training Model for Patients & HCP - of Medtronic, Animas, Insulet Corp & Tandem Diabetes Care

  • 5.1 Medtronic
    • 5.1.1 Training Guidelines for Insulin Pump Therapy to New Patients
    • 5.1.2 Training Model for HCP (HealthCare Professional)
  • 5.2 Insulet Corporation
    • 5.2.1 Training Structure for New Patients - Insulet Corporation
  • 5.3 Animas Corporation
    • 5.3.1 Training Modules for New Patients
    • 5.3.2 Training Modules for HCP (Health Care Professional)
  • 5.4 Tandem Diabetes Care

6. Differentiation Points of Insulin Pump Products Available Worldwide

  • 6.1 Animas Vibe
  • 6.2 Medtronic 530G with Enlite
  • 6.3 Insulet OmniPod
  • 6.4 Tandem t:slim
  • 6.5 Roche Accu-Chek Combo

7. United States - Diabetes Population (2010 - 2024)

  • 7.1 United States Diabetes Population
  • 7.2 United States Type 1 Diabetes Population
  • 7.3 United States Type 2 Diabetes Population

8. United States - Insulin Analysis (2010 - 2024)

  • 8.1 Insulin Pump User & Forecast
  • 8.2 Insulin Pump Market & Forecast
  • 8.3 By States - Reimbursement Policies on Insulin Pump
    • 8.3.1 CALIFORNIA
    • 8.3.2 DELAWARE
    • 8.3.3 FLORIDA
    • 8.3.4 MASSACHUSETTS
    • 8.3.5 MICHIGAN
    • 8.3.6 MONTANA
    • 8.3.7 NEBRASKA
    • 8.3.8 NEW JERSEY
    • 8.3.9 NEW YORK
    • 8.3.10 OKLAHOMA
    • 8.3.11 RHODE ISLAND
    • 8.3.12 SOUTH DAKOTA
    • 8.3.13 TENNESSEE
    • 8.3.14 TEXAS
    • 8.3.15 WASHINGTON

9. Canada - Diabetes Analysis (2010 - 2024)

  • 9.1 Canada Diabetes Population & Forecast
  • 9.2 Type 1 Diabetes Population & Forecast
  • 9.3 Type 2 Diabetes Population

10. Canada Insulin Pump Analysis (2010 - 2024)

  • 10.1 Insulin Pump Users & Forecast
  • 10.2 Insulin Pump Market (2010 - 2024)
  • 10.3 By Province - Insulin Pump Reimbursement policy

11. Germany - Diabetes Analysis (2010 - 2024)

  • 11.1 Germany Diabetes Population & Forecast
  • 11.2 Type 1 Diabetes Population & Forecast
  • 11.3 Type 2 Diabetes Population & Forecast

12. Germany Insulin Pump Analysis (2010 - 2024)

  • 12.1 Insulin Pump Users
  • 12.2 Germany Insulin Pump Market & Forecast
  • 12.3 Reimbursement Policies on Insulin Pump

13. Australia - Diabetes Analysis (2010 - 2024)

  • 13.1 Australia Diabetes Population & Forecast
  • 13.2 Type 1 Diabetes Population & Forecast
  • 13.3 Type 2 Diabetes Population & Forecast

14. Australia Insulin Pump Analysis (2010 - 2024)

  • 14.1 Insulin Pump Users & Forecast
  • 14.2 Insulin Pump Market & Forecast
  • 14.3 Reimbursement Policies on Insulin Pump

15. France - Diabetes Analysis (2010 - 2024)

  • 15.1 France Diabetes Population & Forecast
  • 15.2 Type 1 Diabetes Population & Forecast
  • 15.3 Type 2 Diabetes Population & Forecast

16. France Insulin Pump Analysis (2010 - 2024)

  • 16.1 Insulin Pump Users & Forecast
  • 16.2 Insulin Pump Market & Forecast
  • 16.3 Reimbursement Policies on Insulin pump

17. Netherlands - Diabetes Analysis (2010 - 2024)

  • 17.1 Netherlands Diabetes Population & Forecast
  • 17.2 Type 1 Diabetes Population & Forecast
  • 17.3 Type 2 Diabetes Population & Forecast

18. Netherlands Insulin Pump Analysis (2010 - 2024)

  • 18.1 Insulin Pump Users & Forecast
  • 18.2 Insulin Pump Market & Forecast
  • 18.3 Reimbursement Policies on Insulin Pump

19. Switzerland - Diabetes Analysis (2010 - 2024)

  • 19.1 Switzerland Diabetes Population & Forecast
  • 19.2 Type 1 Diabetes Population & Forecast
  • 19.3 Type 2 Diabetes Population & Forecast

20. Switzerland Insulin Pump Analysis (2010 - 2024)

  • 20.1 Insulin Pump Users & Forecast
  • 20.2 Insulin Pump Market & Forecast
  • 20.3 Reimbursement Policies on Insulin Pump

21. Sweden - Diabetes Analysis (2010 - 2024)

  • 21.1 Sweden Diabetes Population & Forecast
  • 21.2 Type 1 Diabetes Population & Forecast
  • 21.3 Type 2 Diabetes Population & Forecast

22. Sweden Insulin Pump Analysis (2010 - 2024)

  • 22.1 Insulin Pump Users & Forecast
  • 22.2 Insulin Pump Market & Forecast
  • 22.3 Reimbursement Policies on Insulin Pump

23. Israel - Diabetes Analysis (2010 - 2024)

  • 23.1 Israel Diabetes Population & Forecast
  • 23.2 Type 1 Diabetes Population & Forecast
  • 23.3 Type 2 Diabetes Population & Forecast

24. Israel Insulin Pump Analysis (2010 - 2024)

  • 24.1 Insulin Pump Users & Forecast
  • 24.2 Insulin Pump Market & Forecast
  • 24.3 Reimbursement Policies on Insulin Pump

25. United Kingdom - Diabetes Analysis (2010 - 2024)

  • 25.1 Diabetes Population and Forecast
  • 25.2 Type 1 Diabetes Population and Forecast
  • 25.3 Type 2 Diabetes Population and Forecast

26. United Kingdom Insulin Pump Analysis (2010 - 2024)

  • 26.1 Insulin Pump Users & Forecast
  • 26.2 Insulin Pump Market & Forecast
  • 26.3 Reimbursement Policies on Insulin Pump

27. Japan - Diabetes Analysis (2010 - 2024)

  • 27.1 Japan Diabetes Population & Forecast
  • 27.2 Type 1 Diabetes Population & Forecast
  • 27.3 Type 2 Diabetes Population & Forecast

28. Japan Insulin Pump Analysis (2010 - 2024)

  • 28.1 Insulin Pump Users & Forecast
  • 28.2 Insulin Pump Market & Forecast
  • 28.3 Reimbursement Policies on Insulin Pump

29. Key Companies Analysis

  • 29.1 Medtronic
    • 29.1.1 Overview
    • 29.1.2 Insulin Pump - Product Details
    • 29.1.3 Insulin Pump Sales Analysis (2010 - 2024)
    • 29.1.4 Insulin Pump - Latest Development & Trends
  • 29.2 Insulet Corporation
    • 29.2.1 Overview
    • 29.2.2 Insulin Pump - Product Details
    • 29.2.3 Insulin Pump Sales Analysis (2010 - 2024)
    • 29.2.4 Insulin Pump - Latest Development & Trends
  • 29.3 Tandem Diabetes Care
    • 29.3.1 Overview
    • 29.3.2 Insulin Pump Product Details
    • 29.3.3 Insulin Pump Sales Analysis (2012 - 2024)
    • 29.3.4 Insulin Pump - Latest Development & Trends

30. Companies - Insulin Pump Clinical Trials

  • 30.1 Medtronic
  • 30.2 Insulet Corporation
  • 30.3 Tandem Diabetes Care
  • 30.4 Roche
  • 30.5 Animas Corporation

31. Growth Drivers

  • 31.1 Point no. 1
  • 31.2 Point no. 2

32. Challenges

  • 32.1 Point no. 1
  • 32.2 Point no. 2

33. Appendix

List of Figures

  • Figure 2 1: Global - Insulin Pump Users (Number), 2010 - 2016
  • Figure 2 2: Global - Forecast for Insulin Pump Users (Number), 2017 - 2024
  • Figure 3 1: Global - Insulin Pump Market (Million US$), 2010 - 2016
  • Figure 3 2: Global - Forecast for Insulin Pump Market (Million US$), 2017 - 2024
  • Figure 4 1: Global - Key Players Market Share (Percent), 2010 - 2016
  • Figure 4 2: Global - Forecast for Key Players Market Share (Percent), 2017 - 2024
  • Figure 5 1:United States - Overall Diabetes Population (Thousand), 2010 - 2016
  • Figure 5 2:United States - Forecast for Overall Diabetes Population (Thousand), 2017 - 2024
  • Figure 5 3:United States - Type 1 Diabetes Population (Thousand), 2010 - 2016
  • Figure 5 4:United States - Forecast for Type 1 Diabetes Population (Thousand), 2017 - 2024
  • Figure 5 5:United States:Type 2 Diabetes Population (Thousand), 2010 - 2016
  • Figure 5 6:Forecast for Type 2 Diabetes Population (Thousand), 2017 - 2024
  • Figure 6 1:United States - Insulin Pump Users (Number), 2010 - 2016
  • Figure 6 2:United States - Forecast for Insulin Pump Users (Number), 2017 - 2024
  • Figure 7 1:United States - Insulin Pump Market (Million US$), 2010 - 2016
  • Figure 7 2:United States - Forecast for Insulin Pump Market (Million US$), 2017 - 2024
  • Figure 9 1:Canada - Diabetes Population (Thousand), 2010 - 2016
  • Figure 9 2:Canada - Forecast for Diabetes Population (Thousand), 2017 - 2024
  • Figure 9 3:Canada - Type 1 Diabetes Population (Thousand), 2010 - 2016
  • Figure 9 4:Canada - Forecast for Type 1 Diabetes Population (Thousand), 2017 - 2024
  • Figure 9 5:Canada - Type 2 Diabetes Population (Thousand), 2010 - 2016
  • Figure 9 6:Canada - Forecast for Type 2 Diabetes Population (Thousand), 2017 - 2024
  • Figure 10 1:Canada - Insulin Pump User (Number), 2010 - 2016
  • Figure 10 2:Canada - Forecast for Insulin Pump User (Number), 2017 - 2024
  • Figure 11 1:Canada - Insulin Pump Market (Million US$), 2010 - 2016
  • Figure 11 2:Canada - Forecast for Insulin Pump Market (Million US$), 2017 - 2024
  • Figure 13 1:Germany:Diabetes Population (Thousand), 2010 - 2016
  • Figure 13 2:Germany:Forecast for Diabetes Population (Thousand), 2017 - 2024
  • Figure 13 3:Germany:Type 1 Diabetes Population (Thousand), 2010 - 2016
  • Figure 13 4:Germany:Forecast for Type 1 Diabetes Population (Thousand), 2017 - 2024
  • Figure 13 5:Germany:Type 2 Diabetes Population (Thousand), 2010 - 2016
  • Figure 13 6:Germany:Forecast for Type 2 Diabetes Population (Thousand), 2017 - 2024
  • Figure 14 1:Germany - Insulin Pump Users (Number), 2010 - 2016
  • Figure 14 2:Germany - Forecast for Insulin Pump Users (Number), 2017 - 2024
  • Figure 15 1:Germany - Insulin Pump Market (Million US$), 2010 - 2016
  • Figure 15 2:Germany - Forecast for Insulin Pump Market (Million US$), 2017 - 2024
  • Figure 17 1:Australia:Diabetes Population (Thousand), 2010 - 2016
  • Figure 17 2:Australia:Forecast for Diabetes Population (Thousand), 2017 - 2024
  • Figure 17 3:Australia:Type 1 Diabetes Population (Thousand), 2010 - 2016
  • Figure 17 4:Australia:Forecast for Type 1 Diabetes Population (Thousand), 2017 - 2024
  • Figure 17 5:Australia:Type 2 Diabetes Population (Thousand), 2010 - 2016
  • Figure 17 6:Australia:Forecast for Type 2 Diabetes Population (Thousand), 2017 - 2024
  • Figure 18 1:Australia - Insulin Pump Users (Number), 2010 - 2016
  • Figure 18 2:Australia - Forecast for Insulin Pump Users (Number), 2017 - 2024
  • Figure 19 1:Australia - Insulin Pump Market (Million US$), 2010 - 2016
  • Figure 19 2:Australia - Forecast for Insulin Pump Market (Million US$), 2017 - 2024
  • Figure 21 1:France - Diabetes Population (Thousand), 2010 - 2016
  • Figure 21 2:France - Forecast for Diabetes Population (Thousand), 2017 - 2024
  • Figure 21 3:France - Type 1 Diabetes Population (Thousand), 2010 - 2016
  • Figure 21 4:France - Forecast for Type 1 Diabetes Population (Thousand), 2017 - 2024
  • Figure 21 5:France - Type 2 Diabetes Population (Thousand), 2010 - 2016
  • Figure 21 6:France - Forecast for Type 2 Diabetes Population (Thousand), 2017 - 2024
  • Figure 22 1:France - Insulin Pump Users (Number), 2010 - 2016
  • Figure 22 2:France - Forecast for Insulin Pump Users (Number), 2017 - 2024
  • Figure 23 1:France - Insulin Pump Market (Million US$), 2010 - 2016
  • Figure 23 2:France - Forecast for Insulin Pump Market (Million US$), 2017 - 2024
  • Figure 25 1:Netherlands:Diabetes Population (Thousand), 2010 - 2016
  • Figure 25 2:Netherlands:Forecast for Diabetes Population (Thousand), 2017 - 2024
  • Figure 25 3:Netherlands:Type 1 Diabetes Population (Thousand), 2010 - 2016
  • Figure 25 4:Netherlands:Forecast for Type 1 Diabetes Population (Thousand), 2017 - 2024
  • Figure 25 5:Netherlands:Type 2 Diabetes Population (Thousand), 2010 - 2016
  • Figure 25 6:Netherlands:Forecast for Type 2 Diabetes Population (Thousand), 2017 - 2024
  • Figure 26 1:Netherlands - Insulin Pump Users (Number), 2010 - 2016
  • Figure 26 2:Netherlands - Forecast for Insulin Pump Users (Number), 2017 - 2024
  • Figure 27 1:Netherlands - Insulin Pump Market (Million US$), 2010 - 2016
  • Figure 27 2:Netherlands - Forecast for Insulin Pump Market (Million US$), 2017 - 2024
  • Figure 29 1:Switzerland:Diabetes Population (Thousand), 2010 - 2016
  • Figure 29 2:Switzerland:Forecast for Diabetes Population (Thousand), 2017 - 2024
  • Figure 29 3:Switzerland:Type 1 Diabetes Population (Thousand), 2010 - 2016
  • Figure 29 4:Switzerland:Forecast for Type 1 Diabetes Population (Thousand), 2017 - 2024
  • Figure 29 5:Switzerland:Type 2 Diabetes Population (Thousand), 2010 - 2016
  • Figure 29 6:Switzerland:Forecast for Type 2 Diabetes Population (Thousand), 2017 - 2024
  • Figure 30 1:Switzerland - Insulin Pump Users (Number), 2010 - 2016
  • Figure 30 2:Switzerland - Forecast for Insulin Pump Users (Number), 2017 - 2024
  • Figure 31 1:Switzerland - Insulin Pump Market (Million US$), 2010 - 2016
  • Figure 31 2:Switzerland - Forecast for Insulin Pump Market (Million US$), 2017 - 2024
  • Figure 33 1:Sweden:Diabetes Population (Thousand), 2010 - 2016
  • Figure 33 2:Sweden:Forecast for Diabetes Population (Thousand), 2017 - 2024
  • Figure 33 3:Sweden:Type 1 Diabetes Population (Thousand), 2010 - 2016
  • Figure 33 4:Sweden:Forecast for Type 1 Diabetes Population (Thousand), 2017 - 2024
  • Figure 33 5:Sweden:Type 2 Diabetes Population (Thousand), 2010 - 2016
  • Figure 33 6:Sweden:Forecast for Type 2 Diabetes Population (Thousand), 2017 - 2024
  • Figure 34 1:Sweden - Insulin Pump Users (Number), 2010 - 2016
  • Figure 34 2:Sweden - Forecast for Insulin Pump Users (Number), 2017 - 2024
  • Figure 35 1:Sweden - Insulin Pump Market (Million US$), 2010 - 2016
  • Figure 35 2:Sweden - Forecast for Insulin Pump Market (Million US$), 2017 - 2024
  • Figure 37 1:Israel:Diabetes Population (Thousand), 2010 - 2016
  • Figure 37 2:Israel:Forecast for Diabetes Population (Thousand), 2017 - 2024
  • Figure 37 3:Israel:Type 1 Diabetes Population (Thousand), 2010 - 2016
  • Figure 37 4:Israel:Forecast for Type 1 Diabetes Population (Thousand), 2017 - 2024
  • Figure 37 5:Israel:Type 2 Diabetes Population (Thousand), 2010 - 2016
  • Figure 37 6:Israel:Forecast for Type 2 Diabetes Population (Thousand), 2017 - 2024
  • Figure 38 1:Israel - Insulin Pump Users (Number), 2010 - 2016
  • Figure 38 2:Israel - Forecast for Insulin Pump Users (Number), 2017 - 2024
  • Figure 39 1:Israel - Insulin Pump Market (Million US$), 2010 - 2016
  • Figure 39 2:Israel - Forecast for Insulin Pump Market (Million US$), 2017 - 2024
  • Figure 41 1:United Kingdom:Diabetes Population (Thousand), 2010 - 2016
  • Figure 41 2:United Kingdom:Forecast for Diabetes Population (Thousand), 2017 - 2024
  • Figure 41 3:United Kingdom:Type 1 Diabetes Population (Thousand), 2010 - 2016
  • Figure 41 4:United Kingdom:Forecast for Type 1 Diabetes Population (Thousand), 2017 - 2024
  • Figure 41 5:United Kingdom:Type 2 Diabetes Population (Thousand), 2010 - 2016
  • Figure 41 6:United Kingdom:Forecast for Type 2 Diabetes Population (Thousand), 2017 - 2024
  • Figure 42 1:United Kingdom - Insulin Pump Users (Number), 2010 - 2016
  • Figure 42 2:United Kingdom - Forecast for Insulin Pump Users (Number), 2017 - 2024
  • Figure 43 1:United Kingdom - Insulin Pump Market (Million US$), 2010 - 2016
  • Figure 43 2:United Kingdom - Forecast for Insulin Pump Market (Million US$), 2017 - 2024
  • Figure 45 1:Japan:Diabetes Population (Thousand), 2010 - 2016
  • Figure 45 2:Japan:Forecast for Diabetes Population (Thousand), 2017 - 2024
  • Figure 45 3:Japan:Type 1 Diabetes Population (Thousand), 2010 - 2016
  • Figure 45 4:Japan:Forecast for Type 1 Diabetes Population (Thousand), 2017 - 2024
  • Figure 45 5:Japan:Type 2 Diabetes Population (Thousand), 2010 - 2016
  • Figure 45 6:Japan:Forecast for Type 2 Diabetes Population (Thousand), 2017 - 2024
  • Figure 46 1:Japan - Insulin Pump Users (Number), 2010 - 2016
  • Figure 46 2:Japan - Forecast for Insulin Pump Users (Number), 2017 - 2024
  • Figure 47 1:Japan - Insulin Pump Market (Million US$), 2010 - 2016
  • Figure 47 2:Japan - Forecast for Insulin Pump Market (Million US$), 2017 - 2024
  • Figure 49 1: Global - Medtronic Insulin Pump Revenue (Million US$), 2010 - 2016
  • Figure 49 2: Global - Forecast for Medtronic Insulin Pump Revenue (Million US$), 2017 - 2024
  • Figure 49 3:Insulet Corporation - Latest Products
  • Figure 49 4: Global - Insulet Corporation Insulin Pump Revenue (Million US$), 2010 - 2016
  • Figure 49 5: Global - Forecast for Insulet Corporation Insulin Pump Revenue (Million US$), 2017 - 2024
  • Figure 49 6: Global - Tandem Insulin Pump Revenue (Million US$), 2012 - 2016
  • Figure 49 7: Global - Forecast for Tandem Insulin Pump Revenue (Million US$), 2017 - 2024

List of Tables

  • Table 4 1: Global - Insulin Pump Market Share (Percent), 2010 - 2016
  • Table 4 2: Global - Forecast for Insulin Pump Market Share (Percent), 2017 - 2024
  • Table 6 1:Animas Vibe Differentiation Features
  • Table 6 2:Medtronic 530G with Enlite Differentiation Features
  • Table 6 3:Insulet OmniPod Differentiation Features
  • Table 6 4:Tandem t:slim Differentiation Features
  • Table 6 5:Roche Accu-Chek Combo Differentiation Features
  • Table 10 1:Canada - Public Reimbursement Details of Insulin Pump & Pump Supplies by Province
  • Table 10 2:Canada - Insulin Pump & Pump Supplies by Province & Coverage
  • Table 14 1:Australia - Regional Areas Insulin Pump User (Percent), 2013
  • Table 29 1:Medtronic - Latest Insulin Pump Products
  • Table 29 2:Tandem Insulin Pump - Latest Products
Back to Top